AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 194 filers reported holding AXSOME THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 1.52 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $648,789 | -7.7% | 9,283 | -5.1% | 0.01% | 0.0% |
| Q2 2023 | $702,647 | +20.7% | 9,778 | +3.6% | 0.01% | +20.0% |
| Q1 2023 | $582,074 | -11.5% | 9,437 | +10.6% | 0.01% | -16.7% |
| Q4 2022 | $657,842 | +85.8% | 8,529 | +7.5% | 0.01% | +50.0% |
| Q3 2022 | $354,000 | +20.8% | 7,931 | +3.5% | 0.00% | +33.3% |
| Q2 2022 | $293,000 | +6.9% | 7,661 | +15.7% | 0.00% | +50.0% |
| Q1 2022 | $274,000 | +10.0% | 6,623 | +0.5% | 0.00% | 0.0% |
| Q4 2021 | $249,000 | +13.7% | 6,592 | -0.9% | 0.00% | 0.0% |
| Q3 2021 | $219,000 | -50.8% | 6,652 | +0.8% | 0.00% | -50.0% |
| Q2 2021 | $445,000 | -3.7% | 6,598 | -19.1% | 0.00% | 0.0% |
| Q1 2021 | $462,000 | -30.1% | 8,153 | +0.5% | 0.00% | -33.3% |
| Q4 2020 | $661,000 | +10.5% | 8,109 | -3.4% | 0.01% | 0.0% |
| Q3 2020 | $598,000 | +16.3% | 8,391 | +34.2% | 0.01% | -14.3% |
| Q2 2020 | $514,000 | +53.9% | 6,252 | +10.2% | 0.01% | +16.7% |
| Q1 2020 | $334,000 | – | 5,671 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 785,683 | $60,599,730 | 58.10% |
| Fairmount Funds Management LLC | 2,011,647 | $155,158,333 | 24.61% |
| VR Adviser, LLC | 670,718 | $51,732,479 | 8.72% |
| Ghost Tree Capital, LLC | 235,000 | $18,126,000 | 7.74% |
| SVB FINANCIAL GROUP | 33,849 | $2,610,773 | 7.14% |
| Tri Locum Partners LP | 200,054 | $15,430,000 | 6.24% |
| BVF INC/IL | 1,755,000 | $135,363,150 | 5.71% |
| RTW INVESTMENTS, LP | 2,980,482 | $229,884,577 | 4.69% |
| TANG CAPITAL MANAGEMENT LLC | 320,000 | $24,681,600 | 3.59% |
| PFM Health Sciences, LP | 1,092,831 | $84,290,055 | 3.02% |